LAURIE GLIMCHER, MD
Osteopathic Medicine at York Ave, New York, NY
License number
New York 2637891
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
1300 York Ave, New York, NY 10065
Phone
(212) 746-6005
Professional information
Dr. Laurie Glimcher, New York NY - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
1300 York Ave, New York 10065
(212) 746-6005 (Phone)
HARVARD SCHOOL OF PUBLIC HEALTH
651 Huntington Ave SUITE 205, Boston 02115
(617) 432-0622 (Phone)
(212) 746-6005 (Phone)
HARVARD SCHOOL OF PUBLIC HEALTH
651 Huntington Ave SUITE 205, Boston 02115
(617) 432-0622 (Phone)
Certifications:
Internal Medicine, 1979, Rheumatology, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1300 York Ave, New York 10065
HARVARD SCHOOL OF PUBLIC HEALTH
651 Huntington Ave SUITE 205, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
HARVARD SCHOOL OF PUBLIC HEALTH
651 Huntington Ave SUITE 205, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
Harvard Medical School
Graduated: 1976
Massachusetts General Hospital
Harvard Medical School
Graduated: 1976
Massachusetts General Hospital
Methods For Modulating Skeletal Remodeling And Patterning By Modulating Shn2 Activity, Shn3 Activity, Or Shn2 And Shn3 Activity In Combination
US Patent:
2013020, Aug 8, 2013
Filed:
Jan 13, 2011
Appl. No.:
13/521709
Inventors:
Laurie H. Glimcher - New York NY, US
Dallas C. Jones - Brookline MA, US
Marc Wein - Brookline MA, US
Dallas C. Jones - Brookline MA, US
Marc Wein - Brookline MA, US
Assignee:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:
G01N 33/50, A61K 38/17, A61K 31/713, A61K 31/7088
US Classification:
424 92, 514 44 A, 514 167, 514 169, 514 168, 514 166, 506 10, 435375
Abstract:
This invention is based, at least in part, on the discovery that Shn2 and Shn3 play an important role in skeletal remodeling and skeletal patterning. Accordingly, the present invention provides methods for identifying medulators of Shn2 activity and methods for modulating bone formation and mineralization and Shn2-associated disorders using agents that modulate Shn2 expression and/or activity, in addition to methods for modulating Shn2 and Shn3.
Methods For Increasing Immune Responses Using Agents That Directly Bind To And Activate Ire-1
US Patent:
2014003, Jan 30, 2014
Filed:
Feb 7, 2012
Appl. No.:
13/983180
Inventors:
Laurie H. Glimcher - New York NY, US
Assignee:
CORNELL UNIVERSITY - Ithaca NY
International Classification:
A61K 31/675, A61K 31/472, A61K 31/427, A61K 31/513
US Classification:
4242781, 435375, 435 78
Abstract:
The invention provides, e.g., compositions and methods for increasing activation of immune cells.